Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
Régis Peffault de Latour(Hôpital Saint-Louis), Antonio M. Risitano(European Society for Blood and Marrow Transplantation), Constantijn J.M. Halkes(Radboud University Nijmegen), Christian Récher(Institut universitaire du cancer de Toulouse Oncopole), Gèrard Socié(Hôpital Saint-Louis), Talha Munir(Leeds Teaching Hospitals NHS Trust), Jean-Baptiste Méar, Annapaola Iori(Centre Hospitalier Universitaire de Toulouse), Aline Praire(Centre Hospitalier Universitaire de Toulouse), Florence Rabian(Assistance Publique – Hôpitaux de Paris), Morag Griffin(Leeds Teaching Hospitals NHS Trust), Petra Muus(Radboud University Nijmegen), Fabiana Cacace(Duke University), Isabel Sánchez‐Ortega(European Society for Blood and Marrow Transplantation), Riley Cook(Centre Hospitalier Universitaire de Toulouse), Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Nigel H. Russell(Guy's and St Thomas' NHS Foundation Trust), Ursula La Rocca(Centre Hospitalier Universitaire de Toulouse), James D. Cavenagh(National Health Service), Étienne Daguindau(Centre Hospitalier Universitaire de Besançon), Austin Kulasekararaj(King's College London), Fiorenza Barraco(Hôpital Lyon Sud), Serena Marotta(Centre Hospitalier Universitaire de Toulouse), Erfan Nur(Sanquin), Isidro Jarque(Hospital Universitari i Politècnic La Fe), Louis Terriou(Centre Hospitalier Universitaire de Lille), Camilla Frieri(Université Paris Cité), Sofie Terwel(Centre Hospitalier Universitaire de Toulouse), Elena Palmisani(Istituto Giannina Gaslini), Jennifer M.L. Tjon(Leiden University Medical Center), M. Van Lint(Centre Hospitalier Universitaire de Toulouse), Blanca Xicoy(Hospital Universitari Germans Trias i Pujol), Marco R. de Groot(University Medical Center Groningen), Emanuele Angelucci(Ospedale Policlinico San Martino), J. C. Vallejo(Centre Hospitalier Universitaire de Toulouse), Reinier Raymakers(University Medical Center Utrecht), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Flore Sicre de Fontbrune(Assistance Publique – Hôpitaux de Paris), Carlo Dufour(Istituto Giannina Gaslini), Alexander Smith(King's College London), Beatrice Drexler(University Hospital of Basel), Édouard Forcade(Hôpital Cardiologique du Haut-Lévêque), Suzanne Tavitian(Institut universitaire du cancer de Toulouse Oncopole), Simona Iacobelli(Universität Hamburg), Laurence Clément(Centre Hospitalier Universitaire de Bordeaux), Judith Marsh(King's College London), Anita Hill(Leeds General Infirmary), Luana Marano(Centre Hospitalier Universitaire de Toulouse), Ghulam J. Mufti(King's College London), Jakob Passweg(University Hospital of Basel)
Cited by 309
Related Papers
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k